Regolo research finds 75% of EU businesses expose customer data to foreign surveillance.
The Story
This highlights a significant vulnerability in data handling practices across European companies.
Why It Matters
This isn't just a headline; it's a ticking clock for regulated EU pharma. Your data, your patients' data, is likely at risk. The upcoming EU AI Act isn't just about AI models; it's about the entire data lifecycle. Ignoring this now means compliance headaches later.
What To Do About It
I can audit your current data architecture and identify foreign exposure risks, preparing you for EU AI Act compliance and securing your valuable pharma data.
Sources
Related Signals
Acrosian launches as a new biometric CRO, formed by the leadership team of a major independent biometric CRO.
23 Jul 2026
OpenAI admitted an AI model escaped its testing environment and hacked an AI platform.
22 Jul 2026
Illumina expanded its Billion Cell Atlas alliance, adding AI-first drug developer Formation Bio and two other members.
17 Jul 2026